期刊文献+

影响骨肉瘤生存率的多因素回归分析 被引量:8

Cox multivariate regression analysis of survival rate for osteosarcoma
原文传递
导出
摘要 [目的]探讨影响骨肉瘤术后生存的预后因素。[方法]对40例骨肉瘤患者平均随访56个月,计算5年总生存率及无瘤生存率,选择临床因素及分子生物学指标,采用比例风险模型进行多因素回归分析。[结果]本组5年总生存率为53.78%、无瘤生存率为45.00%;Cox多因素回归分析显示:肿瘤体积、肿瘤细胞坏死率(TCNR)、P-gp的表达是影响骨肉瘤术后预后的独立因素。[结论]肿瘤体积、P-gp的表达与骨肉瘤的预后呈负相关,TCNR与预后呈正相关。肿瘤体积、TCNR、P-gp的表达可作为判断预后的独立指标。 [Objective]To determine the independent prognostic factors of survival rate for osteosarcoma. [Methods]The clinical data of 40 patients with osteosarcoma treated in our hospital from 1999 to 2005 were retrospectively analyzed,survival rate was calculated and 7 possible factors influencing survival rate were selected.A multivariate analysis was performed in these patients by the computer's Cox proportional hazard model.[Results]The overall survival rate was 53.78% and the event-free survival rate was 45.00% at five years.The multivariate analysis revealed that the mass of tumor,tumor cell necrosis rate(TCNR) and the expression of P-gp were independent prognostic factors for osteosarcoma.[Conclusion]The mass of tumor,TCNR and the expression of P-gp are the most important prognostic factors for osteosarcoma.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2011年第1期36-39,共4页 Orthopedic Journal of China
关键词 骨肉瘤 预后 回归分析 P-GP PCNA TCNR osteosarcoma prognosis Cox regression analysis P-gp PCNA TCNR
  • 相关文献

参考文献12

  • 1Bacei G, Longhi A, Bertoni F, et al. Primary high -grade osteosarcoma: comparison between preadolescent and older patients [ J ]. J Pediatr Hematol Oncol,2005,27 : 129 - 134.
  • 2于秀淳,徐明,王伟,宋若先.不同新辅助化疗方案治疗骨肉瘤的临床观察[J].中国矫形外科杂志,2008,16(19):1472-1474. 被引量:13
  • 3Bielack SS, Kempf - Bielack B, Delling G, et al. Prognostic factors in high - grade osteosarcoma of the extremities or trunk : an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols[ J ]. J Clin Oncol,2002 ,20 :776 - 790.
  • 4郭全义,卢世璧,张莉,眭翔,田玥,许文静,孙明学.骨肉瘤的治疗及生存率的多因素分析[J].中国矫形外科杂志,2006,14(7):497-499. 被引量:13
  • 5Bacci G, Ferrari S, Bertoni F, et al. Histologic response of high - grade nonmetastatic osteosarcoma of the extremity to chemotherapy [ J ]. Clin Orthop ,2001,386 : 186 - 196.
  • 6Bentzen SM, Poulsen HS, Kaae S ,et al. Prognostic factors in osteosarcomas[J]. Cancer, 1988,62 : 194 - 202.
  • 7Mankin HJ, Hornicek FJ, Rosenberg AE, et al. Survival data for 648 patients with osteosarcoma treated at one institution[ J ]. Clin Orthop, 2004, 429:286-291.
  • 8Bacci G, Briccoli A, Ferrari S ,et al. Neoadjuvant chemotherapy for osteosareoma of the extremity: long - term results of the Rizzoli' s 4^th protocol [ J ]. Eur J Cancer,2001,37:2030 - 2039.
  • 9柳剑,郭卫,杨荣利,曲华毅,杨毅.影像学在评估骨肉瘤新辅助化疗效果中的意义[J].中国矫形外科杂志,2008,16(17):1329-1331. 被引量:4
  • 10Rosen G, Caparros B, Huvos AG,et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy [ J ]. Cancer, 1982,49 : 1221 - 1230.

二级参考文献26

  • 1仲江波,高聿同,张伟,孙成良.人工假体置换在膝关节周围侵袭性骨肿瘤中的应用[J].中国矫形外科杂志,2005,13(3):195-197. 被引量:7
  • 2李建民,杨强,杨志平,丰荣杰,迟增德,李昕.骨肉瘤髓腔内侵袭范围MRI测量与确定合理截骨平面的相关研究[J].中国矫形外科杂志,2005,13(23):1792-1794. 被引量:40
  • 3Ferrari S,Bortoni M,Morcuni M,et al.Predictive factors of disease free survival for non-metatastic osteosarcoma of the extremity:an analysis of 300 patients treated at the Rizzoli institute[J].Ann Oncol,2001,12:1145-1150.
  • 4Holscher HC, Hermans J, Nooy MA,et al. Can conventional radiographs be used to monitor the effect ofneoadjuvant chemotherapy in patients with osteogenic sarcoma [ J ]. Skeletal Radiol, 1996,25 : 19 - 24.
  • 5Shin KH, Moon SH, Sub JS,et al. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma[ J]. Clin Orthop Relat Res, 2000:200 - 208.
  • 6Van der Woude HJ, Bloem JL, Hogendoorn PC. Preoperative evaluation and monitoring chemotherapy in patients with high - grade osteogenic and Ewing's sarcoma: review of current imaging modalities [ J]. Skeletal Radiol, 1998,27:57 -71.
  • 7Brisse H, Ollivier L, Edeline V,et al. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment [ J ]. Pediatr Radiol, 2004,34 : 595 - 605.
  • 8Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma[ J]. Cancer, 2001,91:2230- 2237.
  • 9Uhl M, Saueressig U, van Buiren M, et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion - and perfusion -weighted magnetic resonance imaging [J]. Invest Radiol, 2006,41:618 -623.
  • 10Zhou XJ, Leeds NE, McKinnon GC,et al. Characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging[J]. American Journal of Neuroradiology, 2002,23: 165 - 170.

共引文献26

同被引文献70

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部